Piper Sandler Reiterates Overweight Rating on Madrigal Pharmaceuticals (MDGL)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: MDGL) | Delayed: 385.32 -11 (2.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $396.32 | 52 Week High | $18.24 | |||
| Open | $398.89 | 52 Week Low | $6.60 | |||
| Day High | $401.17 | P/E | N/A | |||
| Day Low | $353.54 | EPS | $0.00 | |||
| Volume | 1,201,657 | |||||
